Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$54.26 ▲ +0.15
(+0.28%)
MKT CAP: $5.25B • VOL: 1.31M
52W L $44 52W H $65
DISCLOSED BUY FLOW
$0
DISCLOSED SELL FLOW
$0
13F HEDGE FUND FILINGS
0 DISCLOSURES
CONGRESSIONAL STOCK ACT
0 FILINGS
CRSP // SEC FORM 4 INSIDERS, 13F WHALES & POLITICIAN LEDGER (OWN <GO>)
WHALE DIRECTORY <13F>
| FILING DATE | FILER / INSTITUTION | CATEGORY | ACTION | SHARES | EXEC PRICE | TOTAL VALUE | DOSSIER |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Citadel Advisors LLC (13F-HR) Institutional Investment Manager | HEDGE_FUND | BUY | 425.0K | $52.09 | $22.1M | TRACK <GO> |
| 2025-02-04 | Executive Officer Form 4 Trust EVP & Chief Financial Officer | INSIDER | SELL | 18.5K | $54.80 | $1.0M | TRACK <GO> |
| 2025-01-28 | Renaissance Technologies LLC 13F Quantitative Holdings | HEDGE_FUND | BUY | 190.0K | $51.00 | $9.7M | TRACK <GO> |